First, Pfizer’s internal trials used a phone app for self-reporting instead of doing actual clinical science. That’s awfully suspicious. Dr. Naomi Wolf goes into detail.
Secondly, Pfizer excluded unfavorable participants from their stage three trials. These groups include: